Cooper Consumer Health is a leading consumer healthcare company headquartered in Paris, currently owned by Damier Group, CVC Capital Partners, Avista Capital Partners and Charterhouse Capital Partners. The company has been transformed from a local French champion into a pan-European pure-play OTC platform that manufactures and distributes a diversified portfolio of branded products on an international basis. The company has more than doubled in size through a combination of organic growth initiatives and targeted M&A activity, consolidating the sector with revenues exceeding €550M. This included the strategic acquisition and integration of international consumer health company Vemedia, a large OTC branded product portfolio from Sanofi, alongside nine other successfully integrated add-ons to complement the brand portfolio. Cooper’s large, international platform has a direct presence in seven European markets and over 30 export markets. It has a wide-ranging portfolio of branded products, including OTC medicines, dietary supplements and medical devices, positioning Cooper as a “one stop shop” for its customers, which include pharmacies, wholesalers and drugstores. The Company is well-placed for further international expansion and organic growth.
